Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 85 results for antidepressants

  1. Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine (HTG408)

    Evidence-based recommendations on transcutaneous stimulation of the cervical branch of the vagus nerve to treat cluster headache and migraine in adults. This involves using a small handheld device to stimulate a nerve in the neck.

    HealthTech guidance
    Published
    23 March 2016
    View recommendations

    Sections for HTG408

  2. Hypersexuality: fluoxetine (ESUOM46)

    Summary of the evidence on fluoxetine for treating hypersexuality to inform local NHS planning and decision-making

    Evidence summary
    Published
    21 July 2015

  3. Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine (HTG643)

    Evidence-based recommendations on transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine in adults. This involves attaching a small device on the forehead to send small electrical currents to the nerves that bring sensation to the upper eyelids, forehead and scalp.

    HealthTech guidance
    Published
    26 October 2022
    View recommendations

    Sections for HTG643

  4. Service models for withdrawal interventions: What service models are most effective in supporting withdrawal from medicines associated with dependence and withdrawal symptoms?

    the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of the evidence and the committee's...

    Research recommendation
    Published
    11 May 2022

  5. Cognitive behavioural therapy (CBT) to support withdrawal from benzodiazepines: What is the most effective model of CBT, including timing of CBT, to support withdrawal from benzodiazepines?

    the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of the evidence and the committee's...

    Research recommendation
    Published
    11 May 2022

  6. Acupuncture to support withdrawal from opioids: What is the clinical and cost effectiveness of acupuncture (including electroacupuncture) as an adjunct to aid withdrawal from opioids?

    the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of the evidence and the committee's...

    Research recommendation
    Published
    11 May 2022

  7. Multicomponent withdrawal interventions: What are the key components of an effective multicomponent intervention to support dose reduction during withdrawal of opioids?

    the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of the evidence and the committee's...

    Research recommendation
    Published
    11 May 2022

  8. Withdrawal interventions for gabapentinoids: What are the most clinically and cost-effective strategies or interventions to aid withdrawal of gabapentinoids?

    the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of the evidence and the committee's...

    Research recommendation
    Published
    11 May 2022

  9. Psychological interventions to support withdrawal: What are the most effective psychological interventions to support withdrawal and help people cope with withdrawal symptoms?

    the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of the evidence and the committee's...

    Research recommendation
    Published
    11 May 2022

  10. Autism spectrum disorder in adults: diagnosis and management (CG142)

    This guideline covers diagnosing and managing suspected or confirmed autism spectrum disorder (autism, Asperger’s syndrome and atypical autism) in people aged 18 and over. It aims to improve access and engagement with interventions and services, and the experience of care, for people with autism.

    Clinical guideline
    Last updated
    14 June 2021
    View recommendations

    Sections for CG142

  11. Rheumatoid arthritis in adults: management (NG100)

    This guideline covers diagnosing and managing rheumatoid arthritis. It aims to improve quality of life by ensuring that people with rheumatoid arthritis have the right treatment to slow the progression of their condition and control their symptoms. People should also have rapid access to specialist care if their condition suddenly worsens.

    NICE guideline
    Last updated
    12 October 2020
    View recommendations

    Sections for NG100

  12. Aids to support withdrawal: What is the effectiveness of equipment, technologies, practical aids and medicine formulations in supporting people to manage dose reductions, compared with usual practice?

    the rationale section on withdrawing a dependence-forming medicine or antidepressant. Full details of the evidence and the committee's...

    Research recommendation
    Published
    11 May 2022

  13. Targeted muscle reinnervation for managing limb amputation pain (HTG750)

    Evidence-based recommendations on targeted muscle reinnervation for managing limb amputation pain. This involves attaching nerves that were cut during limb amputation to other nerves in nearby muscles.

    HealthTech guidance
    Published
    12 June 2025
    View recommendations

    Sections for HTG750

  14. Individual circumstances and the risk of dependence: Do individual circumstances such as social distress, low income or limited access to alternative sources of support lead to an increased risk of problems associated with dependence on prescribed medicines?

    decisions about prescribing and taking a dependence-forming medicine or antidepressant. Full details of the evidence and the committee's...

    Research recommendation
    Published
    11 May 2022

  15. System-level factors and the risk of dependence: Do system-level factors, such as training received by prescribers alter the risk of developing problems associated with dependence on prescribed medicines?

    decisions about prescribing and taking a dependence-forming medicine or antidepressant. Full details of the evidence and the committee's...

    Research recommendation
    Published
    11 May 2022